top of page

UA News and the Unconventional Ag event series are no longer being offered. You can continue to stay updated on the global ag, agtech, food, and food tech sectors through our other publications and events: Global AgInvesting conference series, AgInvesting Weekly, Agtech Intel NewsWomen in Agribusiness Summit, and Women in Agribusiness Today.  We are grateful for your past support, and look forward to staying connected with you through our range of media platforms.


Monsanto Secures FDA Approval for its Biological Corn Seed Treatment

Monsanto has secured approval from the U.S. Food and Drug Administration (FDA) for its biological seed treatment developed to strengthen symbiosis between microbes and corn plants resulting in stronger root systems.

A stronger root system results in greater efficiency in nutrient uptake, and reduces the release of nutrients into the environment. The greater plant biomass also provides a higher level of carbon sequestration in the soil, and the absorption of more carbon dioxide from the air.

Under the project, Corn Bio Yield 2, a collaboration between Monsanto and Novozymes, Acceleron B-360 ST will be used in conjunction with Acceleron B-300, which was released last year, by farmers on four million acres in its first year of release.

Acceleron B-360 ST is scheduled to be released in the U.S. and Canada in 2019, which will then be followed by selective releases in certain EU and Middle East countries pending approval.

NeverStop - 650x85.jpg
CPM Logo Image
LECO Ad Image
MOSOY-NovDecJan-1000 x825-02.png
UA News Subscribe Image


Contact Lynda Kiernan-Stone,

editor of Unconventional Ag News, to submit a story for consideration:

bottom of page